Logsdon et al have used data from the AMP-AD consortium to identify consensus gene clusters that are differentially expressed in Alzheimer’s disease.

The MODEL-AD consortium has worked with nanoString  to develop a transcriptomics panel to assay these modules in mouse models.

We expect that this will be a rapid, cost-effective and highly reproducible approach to assess clinical relevance of novel models, to monitor disease progression, and to assay potential therapeutics.  The transcriptomics panel is now available from nanoString.

 

Skip to toolbar